In vitro and in vivo investigation of metabolic fate of rifampicin using an optimized sample preparation approach and modern tools of liquid chromatography–mass spectrometry
Authors:
- Saranjit SinghSSSaranjit Singh
- 1 October 2009
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 50 (3) , 475-490
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Detoxification reactions: Relevance to agingAgeing Research Reviews, 2008
- In vivo and in vitro metabolism of lefucoxib in ratsJournal of Pharmaceutical and Biomedical Analysis, 2008
- Characterization of the trace‐level impurities in the bulk drug citalopram by high‐performance liquid chromatography/tandem multistage mass spectrometryRapid Communications in Mass Spectrometry, 2007
- Structural elucidation of in vivo and in vitro metabolites of anisodine by liquid chromatography–tandem mass spectrometryJournal of Pharmaceutical and Biomedical Analysis, 2007
- On-line H/D exchange LC–MS strategy for structural elucidation of pharmaceutical impuritiesJournal of Pharmaceutical and Biomedical Analysis, 2007
- A rapid determination of propiverine and its N-oxide metabolite in human plasma by high performance liquid chromatography–electrospray ionization tandem mass spectrometryTalanta, 2005
- Strategies for characterization of drug metabolites using liquid chromatography–tandem mass spectrometry in conjunction with chemical derivatization and on-line H/D exchange approachesJournal of Pharmaceutical and Biomedical Analysis, 2005
- Rifampicin Inhibits α-Synuclein Fibrillation and Disaggregates FibrilsChemistry & Biology, 2004
- Comparative Pharmacokinetics and Pharmacodynamics of the Rifamycin AntibacterialsClinical Pharmacokinetics, 2001
- Clinical Pharmacokinetics of RifampicinClinical Pharmacokinetics, 1978